Plain-English translation of NCT03779009 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing a new fluorescent imaging technique designed to help surgeons better detect cancer spread to lymph nodes during minimally invasive colon cancer surgery. The approach uses a special tracer and camera to identify the lymph nodes most likely to contain cancer cells, making surgery more precise. Researchers also want to understand how cancer changes the immune environment inside lymph nodes to improve detection in the future.
Current methods for detecting cancer spread during colon cancer surgery can miss small areas of disease, and surgeons sometimes remove more tissue than necessary. This new imaging technique could help surgeons be more accurate and thorough while minimizing damage to healthy tissue.
You would undergo minimally invasive (laparoscopic) colon cancer surgery using the new fluorescent imaging technique to detect sentinel lymph nodes during the procedure. Before surgery, you would receive a tracer injection that helps the imaging system identify the lymph nodes most likely to contain cancer. The surgical team would use special optical cameras to visualize these nodes in real time, allowing for more precise removal and testing.
AI-generated summary from trial data ยท Jul 15, 2026 ยท Not medical advice
Belgium
Sponsor
University Hospital, Ghent
Collaborators
Kom Op Tegen Kanker
Enrollment target
~70 participants
Started
March 2018
Primary completion
December 2025
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2024.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Wim Ceelen
University Hospital, Ghent